Aripiprazole: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(→See also: add to, create Notable studies) |
Notjusttired (talk | contribs) m (add missing word) |
||
| Line 21: | Line 21: | ||
==Notable studies == | ==Notable studies == | ||
* 2012, The role of Antipsychotics in the Management of Fibromyalgia | * 2012, The role of Antipsychotics in the Management of Fibromyalgia<ref name="Calandre2012">https://link.springer.com/article/10.2165/11597130-000000000-00000</ref > - [https://link.springer.com/article/10.2165/11597130-000000000-00000 (Abstract)] | ||
==See also== | ==See also== | ||
Revision as of 16:00, April 7, 2020
 | This article is a stub. |
Aripiprazole, which is also sold under the brand names abilify and aripiprazol, is an atypical antipsychotic drug used for a number of different conditions including:
- agitated state
- Autism
- Bipolar disorder (manic depression)
- Borderline Personality Disorder
- Obsessive Compulsive Disorder
- Post-traumatic stress disorder (PTSD)
- Schizophrenia and Schizoaffective Disorder, and
- Tourette's syndrome[1]
Theory
Evidence
Clinicians
Risks and safety
Costs and availability
Notable studies
- 2012, The role of Antipsychotics in the Management of Fibromyalgia[2] - (Abstract)
